| Q78201101 | Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device |
| Q26851303 | Analysis of bacterial biofilms using NMR-based metabolomics |
| Q77711918 | B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression |
| Q53939098 | Bacterial genome sequencing and drug discovery. |
| Q53560132 | Cardiac assist devices. |
| Q42053948 | Cerebral and systemic embolization during left ventricular support with the Novacor N100 device |
| Q73983758 | Clinical impact of infections in left ventricular assist device recipients: the importance of site and organism |
| Q30401758 | Coagulase-negative staphylococci. |
| Q73665809 | Device and patient management in a bridge-to-transplant setting |
| Q73198544 | Diagnosis and management of left ventricular assist device valve-endocarditis: LVAD valve replacement |
| Q54496831 | Effect of high dose platelet inhibitor treatment on thromboembolism in Novacor patients. |
| Q34294909 | Fluconazole in transplant recipients: options and limitations |
| Q53662930 | HLA alloimmunization in patients requiring ventricular assist device support. |
| Q73669683 | Immune response in the early postoperative period after implantation of a left-ventricular assist device system |
| Q28181352 | Infection in ventricular assist devices: prevention and treatment |
| Q40311596 | Infection management in a patient with a left ventricular assist device: a case report of long-term cefazolin sodium hydrate administration |
| Q35999558 | Infections associated with medical devices: pathogenesis, management and prophylaxis |
| Q42246076 | Infectious Complications of Mechanical Circulatory Support (MCS) Devices |
| Q60221529 | Infectious complications in patients with the novacor left ventricular assist system |
| Q44096742 | Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? |
| Q50943516 | Ischemic necrosis of the right colon in a patient with a ventricular assist device system. |
| Q42605586 | LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection |
| Q37949423 | Left ventricular assist device-related infections: past, present and future |
| Q53466433 | Left ventricular assist devices: an ethical analysis. |
| Q74108142 | Long-term mechanical circulatory support with the wearable Novacor left ventricular assist system |
| Q30317657 | Mechanisms of infective endocarditis: pathogen-host interaction and risk states |
| Q74534861 | Nosocomial bloodstream infections in patients with implantable left ventricular assist devices |
| Q47644077 | Outcome of patients surviving to heart transplantation after being mechanically bridged for more than 100 days |
| Q44929448 | Perioperative management of ventricular assist devices |
| Q98466845 | Post-operative infection in mechanical circulatory support patients |
| Q73365178 | Preliminary experience with the lionheart left ventricular assist device in patients with end-stage heart failure |
| Q34996859 | Recipient selection in cardiac transplantation: contraindications and risk factors for mortality. |
| Q43826512 | Relapsing bacteremia in patients with ventricular assist device: an emergent complication of extended circulatory support |
| Q47329016 | Risk factor analysis of Swedish Left Ventricular Assist Device (LVAD) patients |
| Q42272365 | Screening of donor and recipient in solid organ transplantation |
| Q80906275 | Screening of donor and recipient prior to solid organ transplantation |
| Q33438438 | SdrF, a Staphylococcus epidermidis surface protein, contributes to the initiation of ventricular assist device driveline-related infections |
| Q78822798 | Successful treatment of Novacor pump pocket infection by omental transposition |
| Q78081596 | The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study |
| Q36463386 | The role of ionic interactions in the adherence of the Staphylococcus epidermidis adhesin SdrF to prosthetic material |
| Q35807037 | Thymidine auxotrophic Staphylococcus aureus small-colony variant endocarditis and left ventricular assist device infection |
| Q38007865 | Ventricular assist device infections |
| Q28247483 | Ventricular assist device-related infections |
| Q41840900 | Very low ethanol concentrations affect the viability and growth recovery in post-stationary-phase Staphylococcus aureus populations |
| Q35549701 | What Price Support? Ventricular Assist Device Induced Systemic Response |
| Q26853217 | What is the optimum antibiotic prophylaxis in patients undergoing implantation of a left ventricular assist device? |
| Q74255854 | Wound complications after left ventricular assist device implantation |